10,000 Shares in ASP Isotopes Inc. (NASDAQ:ASPI) Bought by Avantax Advisory Services Inc.

Avantax Advisory Services Inc. purchased a new stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI) in the 4th quarter, Holdings Channel reports. The institutional investor purchased 10,000 shares of the company’s stock, valued at approximately $45,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of ASPI. Charles Schwab Investment Management Inc. lifted its position in shares of ASP Isotopes by 16.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 120,278 shares of the company’s stock valued at $334,000 after buying an additional 17,159 shares in the last quarter. The Manufacturers Life Insurance Company bought a new stake in ASP Isotopes during the 3rd quarter worth approximately $52,000. MetLife Investment Management LLC purchased a new position in ASP Isotopes during the third quarter valued at approximately $88,000. Walleye Capital LLC bought a new position in shares of ASP Isotopes in the third quarter worth approximately $536,000. Finally, Verition Fund Management LLC purchased a new stake in shares of ASP Isotopes in the third quarter worth $101,000. Hedge funds and other institutional investors own 16.80% of the company’s stock.

ASP Isotopes Stock Up 12.9 %

Shares of ASPI stock opened at $4.73 on Friday. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54. ASP Isotopes Inc. has a one year low of $1.86 and a one year high of $9.33. The company’s fifty day moving average price is $5.04 and its 200-day moving average price is $4.89. The company has a market capitalization of $337.67 million, a price-to-earnings ratio of -7.75 and a beta of 3.66.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.